Edelweiss Aggressive Hybrid Fund
The scheme seeks to generate long term growth of capital and current income through a portfolio investing predominantly in equity and equity related instruments and the balance in debt and money market securities.
Growthvine rating: 3/5 — ranked #15 of 36 in category.
Fund basics
| Category | Hybrid: Aggressive |
|---|
| NAV | ₹61.49 (as of 2026-10-23) |
|---|
| AUM | ₹3,875 Cr |
|---|
| Expense ratio | 1.56% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Bharat Lahoti |
|---|
| Exit load | For units in excess of 10% of the investment, 1% will be charged for redemption within 90 days |
|---|
Performance & risk
| 5-year annualised return | 10.78% |
|---|
| Sharpe ratio | 0.43 |
|---|
| Standard deviation | 11.78% |
|---|
| Max drawdown | −28.61% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 122.8% of NIFTY 50 Hybrid Composite Debt 65:35 Index's upside and 91.1% of its downside.
Market cap allocation
| Large cap | 63.3% |
|---|
| Mid cap | 19.4% |
|---|
| Small cap | 17.3% |
|---|
Concentration
| Top 5 holdings | 15.6% |
|---|
| Top 10 holdings | 24.7% |
|---|
| Total holdings | 95 |
|---|
Top holdings
- EDELWEISS MONEY MARKET FUND - DIRECT PL — 5.2%
- EDELWEISS ULTRA SHORT TERM FUND — 5.2%
- ICICI Bank Ltd. — 4.2%
- HDFC Bank Ltd. — 3.0%
- Bharti Airtel Ltd. — 3.0%
- Clearing Corporation of India Ltd. — 2.9%
- Reliance Industries Ltd — 2.7%
- State Bank Of India — 2.6%
- Sun Pharmaceutical Industries Ltd. — 2.1%
- NTPC Limited — 2.0%
Top sectors
Not disclosed.
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −5.4% | Q2 | #13 of 33 |
| 2025 | 6.0% | Q3 | #18 of 33 |
| 2024 | 20.2% | Q1 (Top) | #8 of 33 |
| 2023 | 25.4% | Q1 (Top) | #6 of 33 |
| 2022 | 5.3% | Q2 | #9 of 30 |